Botulinum Toxin Use in the Upper Third of the Face

Area of Science:

• Aesthetic medicine
• Neurology
• Dermatology

Background:

• Botulinum toxin (BTX) is a widely used injectable treatment for aesthetic concerns, primarily targeting facial rhytids.
• It is a cornerstone therapy for the upper third of the face in aesthetic procedures.
• Beyond cosmetic applications, BTX demonstrates efficacy in treating numerous functional disorders.

Purpose of the Study:

• To review the current applications and considerations for Botulinum toxin (BTX) use in the upper face.
• To highlight the importance of patient evaluation, selection, and anatomical understanding in achieving successful outcomes and preventing complications.
• To discuss the evolving landscape and expanding indications of neuromodulators in facial aesthetics.

Main Methods:

• Literature review of studies on Botulinum toxin (BTX) for aesthetic and functional indications.
• Analysis of anatomical considerations relevant to upper facial injections.
• Discussion of patient selection criteria and treatment outcomes.

Main Results:

• Botulinum toxin (BTX) is a leading procedure for correcting upper facial rhytids.
• Successful BTX treatment relies heavily on precise patient evaluation and selection.
• A comprehensive understanding of facial anatomy is crucial for minimizing risks and optimizing results.

Conclusions:

• Botulinum toxin (BTX) remains a primary treatment for upper facial aesthetic concerns.
• Patient-specific factors and anatomical knowledge are paramount for safe and effective BTX therapy.
• The therapeutic scope of neuromodulators in the upper face continues to broaden.